Staccato Alprazolam(Engage )

阿普唑仑吸入粉剂

Report date: 2025/09/10 20:01:13

Base Information

Drug NameStaccato Alprazolam(Engage )
Drug Alias NameStaccato AlprazolamStaccato阿普唑仑Staccato alprazolam阿普唑仑吸入粉剂Alprazolam Staccato +[7] 
ClassificationSmall molecules > Heterocyclic drugsDrug and medical devices combination products
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSeizuresEpilepsyAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[14] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEngage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUcb Biopharma SrlAlexza Pharmaceuticals IncGrupo Ferrer Internacional Sa +[6] 
Inactive CompaniesEngage Therapeutics Inc
Active IndicationsSeizuresEpilepsyAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A